International Atomic Energy Agency (IAEA) (2003) VIENNA, Manual for reactor produced radioisotopes. Ranjbar H, Bahrami-Samani A, Beiki D, Shirvani-Arani S, Ghannadi-Maragheh M (2015) Evaluation of 153Sm/ 177Lu-EDTMP mixture in wild-type rodents as a novel combined palliative treatment of bone pain agent.
Stabin MG, Siegel JA (2003) Physical models and dose factors for use in internal dose assessment. Stabin MG (2013) Internal dosimetry in nuclear medicine. Shiraz University of Medical Sciences, Nuclear Medicine Center, Shiraz J Nucl Med 34(11):1839–1844Īlavi MS (2010) Clinical trial project: Lu-177-EDTMP for bone pain palliation of bone metastasis in breast cancer (Project). Radiat Phys Chem 108:60–64Ĭollins C, Eary JF, Donaldson G, Vernon C, Bush NE, Petersdorf S, Livingston RB, Gordon EE, Chapman CR, Appelbaum FR (1993) Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial. Ranjbar H, Ghannadi-Maragheh M, Bahrami-Samani A, Beiki D (2015) Dosimetric evaluation of 153Sm-EDTMP, 177Lu-EDTMP and 166Ho-EDTMP for systemic radiation therapy: Influence of type and energy of radiation and half life of radionuclides. Cancer J 19:71–78įerreira S, Dormehl I, Botelho MF (2012) Radiopharmaceuticals for bone metastasis therapy and beyond: a voyage from the past to the present and a look to the future. Pain Phys 16:309–320īrady D, Parker CC, O’Sullivan JM (2013) Bone-targeting radiopharmaceuticals including radium-223.
#Iaea tecdoc 1839 update
Unit N, Chandra RV (2013) Vertebral augmentation: update on safety, efficacy, cost effectiveness and increased survival.